Methylprednisolone sodium succinate

甲泼尼龙琥珀酸钠

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameMethylprednisolone sodium succinate
Drug Alias Name琥珀酸钠甲基强的松龙methylprednisolonum甲基去氢氢化可的松琥珀酸钠metilprednisolona甲基泼尼松龙琥珀酸钠 +[11] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsCommunity Acquired PneumoniaIschemic StrokeShock, Hemorrhagic +[37] 
Global Approved IndicationsShock, HemorrhagicAddison DiseasePemphigus +[12] 
Approved Indications in ChinaAddison DiseasePemphigusAnemia +[9] 
Original Approved Country/TerritoryUnited States
Original Approved Date1959/04/02
Country/TerritoryUnited StatesItalyEgypt +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Second Affiliated Hospital of the Air Force Medical University of the Chinese People's Liberation ArmyFirst Affiliated Hospital Of Fujian Medical UniversityMazandaran University Of Medical Sciences +[8] 
Inactive CompaniesNational Institute Of Arthritis And Musculoskeletal And Skin DiseasesLouisiana State University Health Sciences Center In New OrleansAlexandria University
Active IndicationsCommunity Acquired PneumoniaIschemic StrokeShock, Hemorrhagic +[30] 
Inactive IndicationsEndocrine System DiseasesEye DiseasesCarpal Tunnel Syndrome +[7] 

Other Information

ATC CodeD07AA01D10AA02H02AB04
Related LinksWikipediaDrugBankKEGG